Evvy Raises $40M Series B to Advance Women's Vaginal Microbiome Research
Women's health startup Evvy has secured $40 million in a Series B funding round, with Catalio Capital Management leading the investment. The company focuses on advancing women's health research through the study of vaginal microbiome data. The announcement was made on Tuesday. The funding is expected to help Evvy expand its research capabilities and deepen its understanding of how vaginal microbiome health affects women's overall wellbeing.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in